Share ownership AbbVie Inc.

ABBV

US00287Y1091

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 21:06:35 15/04/2026 BST			5-day change	1st Jan Change
208.52 ^USD	-0.00%		-1.31%	-8.61%

05:07pm	Johnson & Johnson Reported Above-Peer Topline Growth in Q1, BofA Says	MT
10:11am	RemeGen Receives $650 Million Upfront Payment From AbbVie Under Licensing Agreement	MT

Share class: AbbVie Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,831,450,749	1,765,407,270 ( 96.39 %)	64,310,426 ( 3.511 %)	96.39 %

Major shareholders: AbbVie Inc.

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 10.22 %	180,779,699	10.22 %	39 318 M $
BlackRock Advisors LLC 6.377 %	112,751,940	6.377 %	24 522 M $
STATE STREET CORPORATION 4.578 %	80,940,931	4.578 %	17 604 M $
JPMorgan Investment Management, Inc. 2.963 %	52,393,323	2.963 %	11 395 M $
Geode Capital Management LLC 2.524 %	44,629,980	2.524 %	9 707 M $
Eaton Vance Management 2.265 %	40,041,939	2.265 %	8 709 M $
BlackRock Life Ltd. 1.92 %	33,949,276	1.92 %	7 384 M $
Merrill Lynch International 1.461 %	25,824,399	1.461 %	5 617 M $
Norges Bank (13F) 1.452 %	25,668,761	1.452 %	5 583 M $
Capital Research & Management Co. (Global Investors) 1.437 %	25,408,200	1.437 %	5 526 M $
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Caixa DTVM SA 0.001038 %	293,772	0.001038 %	4 M $
XP Allocation Asset Management Ltda. 0.000003 %	768	0.000003 %	10 357 $

Breakdown by shareholder type

Institutional	59.69%
Other	7.99%
State Street Corp.	4.58%
Schweizerische Nationalbank	0.27%
Sumitomo Mitsui Trust Group, Inc.	0.23%
Manulife Financial Corp.	0.17%
Governments	0.14%
Swedbank AB	0.11%
Fifth Third Bancorp	0.08%
Danske Bank A/S	0.07%
Individuals	0.07%
SEI Investments Co.	0.06%
Menora Mivtachim Holdings Ltd.	0.06%
Skandinaviska Enskilda Banken AB	0.05%
ABN AMRO Bank NV	0.05%
ING Groep NV	0.04%
The Bank of Nova Scotia	0.04%
Regions Financial Corp.	0.04%
Cincinnati Financial Corp.	0.03%
Migdal Insurance & Financial Holdings Ltd.	0.02%
Cullen/Frost Bankers, Inc.	0.02%
Zurich Insurance Group AG	0.02%
Banco Bilbao Vizcaya Argentaria SA	0.02%
Peapack-Gladstone Financial Corp.	0.01%
Münchener Rückversicherungs-Gesellschaft AG	0.01%
The Allstate Corp.	0.01%
Hancock Whitney Corp.	0.01%
Silvercrest Asset Management Group, Inc.	0.01%
Hikari Tsushin, Inc.	0.01%
Banque Cantonale Vaudoise	0.01%
Unknown	26.08%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	55.75%
United Kingdom	7.39%
Canada	2.43%
Norway	1.58%
France	0.96%
Germany	0.86%
Sweden	0.72%
Japan	0.71%
Australia	0.6%
Netherlands	0.47%
Switzerland	0.44%
Denmark	0.42%
South Korea	0.3%
Luxembourg	0.27%
Hong Kong	0.24%
Italy	0.15%
Israel	0.08%
Ireland	0.08%
Individuals	0.07%
Finland	0.07%
Belgium	0.07%
Spain	0.06%
Austria	0.06%
New Zealand	0.03%
Czech Republic	0.03%
Liechtenstein	0.02%
Brazil	0.02%
Singapore	0.01%
Malaysia	0.01%
China	0.01%
Slovenia	0.01%
South Africa	0.01%

Based on 1000 largest holdings

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).

Employees

57,000

Sector

Pharmaceuticals

Calendar

05:00am - Ex-dividend date - 1.73 USD

More about the company